First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria

Denis Niyazi; Borislava Toncheva; Tsvetan Tonchev; Deyan Dzhenkov; Kalin Kalchev; Temenuga Stoeva

doi:10.2217/fmb-2022-0030

First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria

Future Microbiol. 2022 Sep:17:1107-1113. doi: 10.2217/fmb-2022-0030. Epub 2022 Jul 28.

Authors

Denis Niyazi^{1

2}, Borislava Toncheva^{3

2}, Tsvetan Tonchev^{3

2}, Deyan Dzhenkov^{4

2}, Kalin Kalchev^{4

2}, Temenuga Stoeva^{1

2}

Affiliations

¹ Laboratory of Clinical Microbiology, University Hospital 'St. Marina', Varna, Bulgaria.
² Medical University, Varna, Bulgaria.
³ Maxillofacial Surgery Clinic, University Hospital 'St. Marina', Varna, Bulgaria.
⁴ General & clinical pathology clinic, University Hospital 'St. Marina', Varna, Bulgaria.

Abstract

Mucormycosis is a relatively rare infection but with a high mortality rate due to the difficult and time-consuming diagnostic and therapeutic process. The authors present the first case of rhino-orbital-cerebral mucormycosis, histologically and microbiologically proven, in a patient after COVID-19 infection in Bulgaria.

Keywords: Bulgaria; COVID-19; diagnosis; rhino-orbital-cerebral mucormycosis; risk factors.

Publication types

Case Reports

MeSH terms

Bulgaria
COVID-19* / complications
Humans
Mucormycosis* / diagnosis
Mucormycosis* / drug therapy
Mucormycosis* / microbiology
Orbital Diseases* / diagnosis
Orbital Diseases* / microbiology
Orbital Diseases* / pathology
Tomography, X-Ray Computed